BBH Holdings Information

BBH is an equity ETF with a total of 25 individual holdings. The top holdings are Amgen stock at 16.16%, Gilead Sciences at 12.79%, Vertex Pharmaceuticals at 10.80%, Regeneron Pharmaceuticals at 5.36%, and argenx SE at 4.77%.

Total Holdings

Top 10 Percentage

70.27%

Asset Class

Equity

ETF Category

Health

Assets

339.74M

PE Ratio

20.45

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	16.16%	185,964
2	GILD	Gilead Sciences, Inc.	12.79%	396,248
3	VRTX	Vertex Pharmaceuticals Incorporated	10.80%	78,296
4	REGN	Regeneron Pharmaceuticals, Inc.	5.36%	32,059
5	ARGX	argenx SE	4.77%	28,914
6	ALNY	Alnylam Pharmaceuticals, Inc.	4.64%	50,111
7	IQV	IQVIA Holdings Inc.	4.51%	94,205
8	NTRA	Natera, Inc.	4.24%	89,726
9	BIIB	Biogen Inc.	3.56%	90,106
10	INSM	Insmed Incorporated	3.44%	119,230
11	ICLR	ICON Public Limited Company	3.21%	72,511
12	BNTX	BioNTech SE	3.05%	91,955
13	ILMN	Illumina, Inc.	3.03%	103,626
14	NBIX	Neurocrine Biosciences, Inc.	2.93%	74,600
15	MRNA	Moderna, Inc.	2.77%	280,019
16	ONC	BeOne Medicines Ltd.	2.72%	36,947
17	INCY	Incyte Corporation	2.02%	99,836
18	TECH	Bio-Techne Corporation	1.81%	113,507
19	QGEN	Qiagen N.V.	1.68%	118,751
20	CRL	Charles River Laboratories International, Inc.	1.65%	35,076
21	BMRN	BioMarin Pharmaceutical Inc.	1.56%	91,303
22	EXAS	Exact Sciences Corporation	1.49%	97,293
23	RGEN	Repligen Corporation	1.41%	36,777
24	SRPT	Sarepta Therapeutics, Inc.	0.36%	68,233
25	n/a	Us Dollar	0.04%	140,090

As of Jul 12, 2025